U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
100861100861Effect of Statins on Lipid Levels Following the First Acute Coronary Event (MK-0000-204)CompletedHas ResultsDyslipidemias|Hypercholesterolemia|Hypertriglyceridemia|High LDL-C|Low HDL-Chttps://ClinicalTrials.gov/show/NCT01245738
100862100862Aggrastat Truncated Length Against Standard Therapies in Percutaneous Coronary InterventionSuspendedNo Results AvailableMyocardial Infarction|Acute Coronary Syndromes|Unstable Angina|Percutaneous Coronary InterventionDrug: Tirofiban (Aggrastat)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01245725
100863100863Partial Breast Proton Beam IrradiationRecruitingNo Results AvailableBreast CancerRadiation: Accelerated Partial Breast Irradiation (APBI)https://ClinicalTrials.gov/show/NCT01245712
100864100864MIHS Emergency Department CPR Quality Improvement ProjectRecruitingNo Results AvailableCardiac Arresthttps://ClinicalTrials.gov/show/NCT01245699
100865100865Heart to Health: A Combined Lifestyle and Medication Intervention to Reduce Cardiovascular Disease (CVD) RiskCompletedNo Results AvailableCardiovascular Disease|Coronary Heart DiseaseBehavioral: Lifestyle and medication interventionhttps://ClinicalTrials.gov/show/NCT01245686
100866100866Combination Immunotherapy and Autologous Stem Cell Transplantation for MyelomaCompletedNo Results AvailableAdvanced Myeloma.Biological: Prevnar- Pneumococcal Conjugate Vaccine (PCV)|Other: Activated/costimulated autologous T-cell|Drug: Lenalidomide|Biological: MAGE-A3, Hiltonol® (Poly-ICLC)https://ClinicalTrials.gov/show/NCT01245673
100867100867A Phase 0 of Neoadjuvant Lapatinib in Infiltrative Bladder Carcinoma Before CystectomyTerminatedNo Results AvailableBladder Carcinoma|Infiltrative Bladder Carcinoma|CystectomyDrug: LAPATINIBhttps://ClinicalTrials.gov/show/NCT01245660
100868100868Will Having Alcohol Treatment Improve Functioning?CompletedHas ResultsHIV|AlcoholismDrug: Naltrexone, 50mg, once per day for 4 months|Other: Sugar pill, 50mg, once per day for 4 monthshttps://ClinicalTrials.gov/show/NCT01245647
100869100869A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) SurgeryCompletedNo Results AvailableCoronary Heart Disease, Graft Occlusion, VascularDrug: Placebo|Drug: RO4905417https://ClinicalTrials.gov/show/NCT01245634
100870100870Study of Palliative Care Intervention for Advanced Cancer Patients and Their Caregivers -Educate Nurture Advise Before Life Ends (ENABLE III)CompletedNo Results AvailableAdvanced CancerBehavioral: Later entry group|Behavioral: Early palliative care interventionhttps://ClinicalTrials.gov/show/NCT01245621
100871100871Prevention of Cardiovascular Disease Using a Single PolyPill in an Urban Population - Focus on Liver-Related Variables.Active, not recruitingNo Results AvailableCardiovascular DiseasesDrug: Polypillhttps://ClinicalTrials.gov/show/NCT01245608
100872100872Aminophylline to Prevent Acute Kidney Injury in Children After Cardiac SurgeryCompletedHas ResultsAcute Kidney InjuryDrug: Aminophylline|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01245595
100873100873Oxaliplatin and Capecitabine on Top of Sorafenib Versus Sorafenib Alone in Advanced Hepatocellular Carcinoma PatientsWithdrawnNo Results AvailableHepatic Neoplasm MalignantDrug: oxaliplatin (SR96669)|Drug: capecitabine|Drug: sorafenibhttps://ClinicalTrials.gov/show/NCT01245582
100874100874A Study in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNo Results AvailableChronic Obstructive Pulmonary DiseaseDrug: Foster® 100/6 µg/unit dose|Drug: Seretide Accuhaler® 500/50 µg/actuationhttps://ClinicalTrials.gov/show/NCT01245569
100875100875Safety and Efficacy Study of BMS-908662 in Combination With Ipilimumab in Subjects With Advanced MelanomaCompletedNo Results AvailableMelanomaDrug: BMS-908662|Drug: BMS-908662|Drug: Ipilimumab|Drug: Ipilimumabhttps://ClinicalTrials.gov/show/NCT01245556
100876100876Safety Study for Intravenous (IV) AC480 (AC480IV) to Treat Advanced Solid TumorsWithdrawnNo Results AvailableSolid TumorsDrug: AC480IV|Drug: Docetaxelhttps://ClinicalTrials.gov/show/NCT01245543
100877100877An Efficacy and Safety Study of INM-176 for the Treatment of Patients With Alzheimer Type DementiaCompletedNo Results AvailableAlzheimer Type DementiaDrug: Aricept|Drug: INM-176https://ClinicalTrials.gov/show/NCT01245530
100878100878The Influence of Dietary Phosphorus Education Program on Nutritional Status and Serum Phosphate Level Among Hemodialysis PatientRecruitingNo Results AvailableHyperphosphatemia|MalnutritionOther: Educationhttps://ClinicalTrials.gov/show/NCT01245517
100879100879Assessment of Socket Shapes Made by Central Fabrication FacilitiesCompletedNo Results AvailablePeople With Lower Limb Amputation That Are AmbulatoryOther: Assessed for socket fithttps://ClinicalTrials.gov/show/NCT01245504
100880100880The Effects of Vibration on HypoxiaCompletedNo Results AvailableHypoxiaOther: Vibrationhttps://ClinicalTrials.gov/show/NCT01245491
100881100881DePuy Revision TKA Implant 5yr SurvivorshipWithdrawnNo Results AvailableComplications; Arthroplasty, Mechanicalhttps://ClinicalTrials.gov/show/NCT01245478
100882100882Profermin® in Active Ulcerative ColitisCompletedNo Results AvailableUlcerative ColitisOther: Proferminhttps://ClinicalTrials.gov/show/NCT01245465
100883100883Study of the Response and Cardiorespiratory Endurance in Early RA Patients Treated With Tocilizumab or MethotrexateCompletedNo Results AvailableRheumatoid ArthritisDrug: Tocilizumab|Drug: Methotrexatehttps://ClinicalTrials.gov/show/NCT01245452
100884100884A Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid ArthritisCompletedNo Results AvailableRheumatoid ArthritisDrug: tocilizumab [RoActemra/Actemra]https://ClinicalTrials.gov/show/NCT01245439
100885100885A Study in Asthmatics to Determine the Efficacy and Dose Response of Repeat Doses of GW870086X on Forced Expiratory Volume in 1 Second (FEV1)CompletedNo Results AvailableAsthmaDrug: GW870086 2mg|Drug: GW870086 4mg|Drug: GW870086 Placebo|Drug: GW870086 1mg|Drug: GW870086 3mghttps://ClinicalTrials.gov/show/NCT01245426
100886100886Controlled Randomized Study With Athena Base Plate Versus SenSura Base Plate on Perspiring SkinCompletedHas ResultsHealthyDevice: SenSura|Device: Athenahttps://ClinicalTrials.gov/show/NCT01245413
100887100887Safety and Efficacy Study of the Z-Lig Medical Device Compared to AllograftActive, not recruitingNo Results AvailableRuptured Anterior Cruciate LigamentsDevice: Z-Lig|Device: allografthttps://ClinicalTrials.gov/show/NCT01245400
100888100888Observational Study Of The Long-Term Effect Of Macugen In Patients With Wet Age-Related Macular DegenerationCompletedHas ResultsMacular Degeneration|Age-related Macular Degeneration|Neovascular Macular DegenerationDrug: Pegaptanibhttps://ClinicalTrials.gov/show/NCT01245387
100889100889Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or ParentsCompletedHas ResultsGrowth Hormone Disorder|Growth Hormone Deficiency in Children|Foetal Growth Problem|Small for Gestational Age|Genetic Disorder|Turner Syndrome|Chronic Kidney Disease|Chronic Renal Insufficiency|Delivery SystemsDrug: Norditropin NordiFlex®https://ClinicalTrials.gov/show/NCT01245374
100890100890A 6-Months Infliximab Or Placebo Study In UA At High Risk Of RA:Clinical,Radiological And Synovial BenefitCompletedNo Results AvailableUndifferentiated ArthritisDrug: Infliximab|Drug: sodium chloridehttps://ClinicalTrials.gov/show/NCT01245361

* Görseller ve İçerik tekif hakkına sahip olabilir